Skip to content

SOLV

Solventum Corporation

NYSE · Healthcare · Medical - Care Facilities · US

$91.69
−0.81%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue8.3B8.3B8.3B8.2B8.1B
Cost of Revenue3.8B3.9B3.7B3.5B3.4B
Gross Profit4.5B4.5B4.6B4.7B4.7B
Operating Expenses
R&D Expense726.0M739.0M775.0M758.0M767.0M
SG&A Expense3.3B3.1B2.8B2.2B2.2B
General & Admin Expense827.0M
Selling & Marketing Expense
Other Expenses(1.6B)(1.5B)
Total Operating Expenses2.5B2.3B3.6B3.0B3.0B
Cost and Expenses6.2B6.1B7.2B6.5B6.4B
Operating Income (EBIT)2.1B2.2B1.0B1.7B1.7B
Non-Operating
Interest Income
Interest Expense266.0M347.0M367.0M
Net Interest Income(266.0M)(347.0M)(367.0M)
Other Non-Op Income/Expense(381.0M)(468.0M)(431.0M)(25.0M)(1.0M)
Non-Operating Income (excl Interest)115.0M121.0M64.0M25.0M1.0M
EBT (Pre-Tax Income)1.7B1.7B605.0M1.7B1.7B
Income Tax Expense261.0M157.0M127.0M321.0M349.0M
Bottom Line
Net Income1.4B1.6B479.0M1.3B1.3B
Earnings from Cont. Ops1.4B1.6B478.0M1.3B1.3B
Earnings from Discont. Ops
Bottom Line Net Income1.4B1.6B479.0M1.3B1.3B
Per Share
Basic EPS$8.22$8.94$2.77$7.79$7.79
Diluted EPS$8.19$8.88$2.76$7.79$7.79
Revenue Per Share$47.90$47.82$47.66$47.46$47.14
Shares
Basic Shares Outstanding173.5M174.1M173.2M172.7M172.5M
Diluted Shares Outstanding174.4M175.3M173.7M172.7M172.5M
Profitability Metrics
EBITDA2.6B2.5B1.5B2.2B2.3B
D&A636.0M489.0M555.0M561.0M578.0M
EBIT2.0B2.1B972.0M1.7B1.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026